178 related articles for article (PubMed ID: 35602711)
1. Breast Cancer Survivors' Lived Experience of Adjuvant Hormone Therapy: A Thematic Analysis of Medication Side Effects and Their Impact on Adherence.
Ibrar M; Peddie N; Agnew S; Diserholt A; Fleming L
Front Psychol; 2022; 13():861198. PubMed ID: 35602711
[TBL] [Abstract][Full Text] [Related]
2. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A qualitative systematic review and thematic synthesis.
Peddie N; Agnew S; Crawford M; Dixon D; MacPherson I; Fleming L
Breast; 2021 Aug; 58():147-159. PubMed ID: 34049260
[TBL] [Abstract][Full Text] [Related]
3. Patients' Experience of Medication Brand Changes during Hormone Therapy for Breast Cancer-An Interpretative Phenomenological Analysis.
Eraso Y; Moon Z; Steinberga I
Healthcare (Basel); 2022 Dec; 10(12):. PubMed ID: 36554081
[TBL] [Abstract][Full Text] [Related]
4. The impact of medication side effects on adherence and persistence to hormone therapy in breast cancer survivors: A quantitative systematic review.
Fleming L; Agnew S; Peddie N; Crawford M; Dixon D; MacPherson I
Breast; 2022 Aug; 64():63-84. PubMed ID: 35609380
[TBL] [Abstract][Full Text] [Related]
5. The lived experience of breast cancer patients on adjuvant endocrine therapy: Side effects and coping strategies during the first year of medication initiation.
Gomaa S; Lopez A; Slamon R; Smith R; Telushi E; Lapitan E; Nightingale G; Miller S; Wen KY
Res Sq; 2023 Jan; ():. PubMed ID: 36778385
[TBL] [Abstract][Full Text] [Related]
6. Deconstructing Decisions to Initiate, Maintain, or Discontinue Adjuvant Endocrine Therapy in Breast Cancer Survivors: A Mixed-Methods Study.
Bluethmann SM; Murphy CC; Tiro JA; Mollica MA; Vernon SW; Bartholomew LK
Oncol Nurs Forum; 2017 May; 44(3):E101-E110. PubMed ID: 28635973
[TBL] [Abstract][Full Text] [Related]
7. The Patient's Voice: Adherence, Symptoms, and Distress Related to Adjuvant Endocrine Therapy After Breast Cancer.
Jacobs JM; Walsh EA; Park ER; Berger J; Peppercorn J; Partridge A; Horick N; Safren SA; Temel JS; Greer JA
Int J Behav Med; 2020 Dec; 27(6):687-697. PubMed ID: 32495240
[TBL] [Abstract][Full Text] [Related]
8. Understanding tamoxifen adherence in women with breast cancer: A qualitative study.
Moon Z; Moss-Morris R; Hunter MS; Hughes LD
Br J Health Psychol; 2017 Nov; 22(4):978-997. PubMed ID: 28850763
[TBL] [Abstract][Full Text] [Related]
9. The experience of cancer-related fatigue, exercise and exercise adherence among women breast cancer survivors: Insights from focus group interviews.
Kim S; Han J; Lee MY; Jang MK
J Clin Nurs; 2020 Mar; 29(5-6):758-769. PubMed ID: 31769562
[TBL] [Abstract][Full Text] [Related]
10. Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelines.
Hall LH; King NV; Graham CD; Green SMC; Barber A; Neal RD; Foy R; Clark J; Lloyd KE; Smith SG
J Cancer Surviv; 2022 Dec; 16(6):1296-1338. PubMed ID: 34664199
[TBL] [Abstract][Full Text] [Related]
11. "I Beat Cancer to Feel Sick:" Qualitative Experiences of Sleep Disturbance in Black Breast Cancer Survivors and Recommendations for Culturally Targeted Sleep Interventions.
Geiss C; Chavez MN; Oswald LB; Ketcher D; Reblin M; Bandera EV; Savard J; Zhou ES; Fox RS; Jim HSL; Gonzalez BD
Ann Behav Med; 2022 Nov; 56(11):1110-1115. PubMed ID: 35759312
[TBL] [Abstract][Full Text] [Related]
12. Understanding Breast Cancer Survivors' Beliefs and Concerns About Adjuvant Hormonal Therapy: Promoting Adherence.
Hurtado-de-Mendoza A; Jensen RE; Jennings Y; Sheppard VB
J Cancer Educ; 2018 Apr; 33(2):436-439. PubMed ID: 28205022
[TBL] [Abstract][Full Text] [Related]
13. Adherence to adjuvant tamoxifen and associated factors in breast cancer survivors.
Uslu Y; Kocatepe V; Sezgin DS; Uras C
Support Care Cancer; 2023 Apr; 31(5):285. PubMed ID: 37079089
[TBL] [Abstract][Full Text] [Related]
14. Behavioral Interventions to Enhance Adherence to Hormone Therapy in Breast Cancer Survivors: A Systematic Literature Review.
Hurtado-de-Mendoza A; Cabling ML; Lobo T; Dash C; Sheppard VB
Clin Breast Cancer; 2016 Aug; 16(4):247-255.e3. PubMed ID: 27133733
[TBL] [Abstract][Full Text] [Related]
15. Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study.
Wells KJ; Pan TM; Vázquez-Otero C; Ung D; Ustjanauskas AE; Muñoz D; Laronga C; Roetzheim RG; Goldenstein M; Carrizosa C; Nuhaily S; Johnson K; Norton M; Sims E; Quinn GP
Support Care Cancer; 2016 Oct; 24(10):4123-30. PubMed ID: 27146492
[TBL] [Abstract][Full Text] [Related]
16. Acceptability, fidelity and trial experience of four intervention components to support medication adherence in women with breast cancer: A process evaluation protocol for a pilot fractional factorial trial.
Green SMC; Hall LH; Rousseau N; French DP; Graham CD; Collinson M; Mason E; Wilkes H; Howdon D; Foy R; Walwyn R; Clark J; Parbutt C; Raine E; Ellison R; Buxton J; Moore SJL; Velikova G; Farrin A; Smith SG
NIHR Open Res; 2023; 3():3. PubMed ID: 37881449
[TBL] [Abstract][Full Text] [Related]
17. Home-based multidimensional survivorship programmes for breast cancer survivors.
Cheng KKF; Lim YTE; Koh ZM; Tam WWS
Cochrane Database Syst Rev; 2017 Aug; 8(8):CD011152. PubMed ID: 28836379
[TBL] [Abstract][Full Text] [Related]
18. A mixed-methods study of the technical feasibility and patient acceptability of a real-time adherence monitor in breast cancer survivors taking adjuvant endocrine therapy.
Bright EE; Genung SR; Stanton AL; Arch JJ
Breast Cancer Res Treat; 2022 Oct; 195(3):393-399. PubMed ID: 35962148
[TBL] [Abstract][Full Text] [Related]
19. Psychosocial factors in adjuvant hormone therapy for breast cancer: an emerging context for adherence research.
Van Liew JR; Christensen AJ; de Moor JS
J Cancer Surviv; 2014 Sep; 8(3):521-31. PubMed ID: 24986227
[TBL] [Abstract][Full Text] [Related]
20. The untold story of late effects: a qualitative analysis of breast cancer survivors' emotional responses to late effects.
Rosenberg J; Butow PN; Shaw JM
Support Care Cancer; 2022 Jan; 30(1):177-185. PubMed ID: 34245359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
